Patents by Inventor Debajit K. Biswas

Debajit K. Biswas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040126385
    Abstract: A method of screening, diagnosing, or treating an NF-&kgr;B induced pathology through the use of NF-&kgr;B modulating agents. These cells isolated from pathological regions of a subject can be cultured in the presence or absence of a modulating agent to detect a change in proliferation of the cells, wherein a change in proliferation in modulator treated cells compared to control cells shows that the cells are derived from an NF-&kgr;B induced pathology. A subject that contains cells derived from an NF-&kgr;B induced pathology can be diagnosed with this pathology. NF-&kgr;B modulators can then be used to treat the NF-&kgr;B induced pathology.
    Type: Application
    Filed: August 27, 2002
    Publication date: July 1, 2004
    Inventors: Debajit K. Biswas, Arthur B. Pardee
  • Patent number: 5762931
    Abstract: This invention relates to a method of combatting cancer which cancer releases chorionic gonadotropin or a subunit thereof present in a mammal which method comprises administering to said animal an anti-cancer effective amount of a birth-control vaccine or an antibody to said chorionic gonadotropin or subunit thereof. Birth-control vaccines which are polyvalent vaccines and birth-control vaccines which employ recombinant organisms incorporating sequences coding for reproductive hormones are of particular interest as well as polyclonal and monoclonal antibodies to the chorionic gonadotropin.
    Type: Grant
    Filed: November 7, 1994
    Date of Patent: June 9, 1998
    Assignee: National Institute of Immunology
    Inventors: Gursaran P. Talwar, Debajit K. Biswas
  • Patent number: 5641773
    Abstract: The present invention includes, inter alia, methods of treating cells infected with a virus capable of causing an immunodeficiency disease and related pharmaceutical compositions.
    Type: Grant
    Filed: November 30, 1993
    Date of Patent: June 24, 1997
    Assignee: Dana-Farber Cancer Institute
    Inventors: Arthur P. Pardee, Debajit K. Biswas, Bruce J. Dezube
  • Patent number: 4766067
    Abstract: Hybrid DNA capable of effecting controlled amplification in a host cell of a heterologous gene that determines a specific function. The hybrid DNA has the following three different regions of DNA: (1) an "amplicon" that is inducible by an external stimulus; (2) the heterologous gene (or a site for its insertion); and (3) a selectable marker enabling isolation of the transformed host cells. In order to make a desired compound coded by the heterologous gene, a vehicle including the hybrid DNA is introduced into a host cell is transformed with the vector, transformed host cells are grown to a desired population, the external stimulus is controlled to effect amplification of the gene in members of the population, cells containing amplified gene are cultured, and the compound is recovered.
    Type: Grant
    Filed: May 31, 1985
    Date of Patent: August 23, 1988
    Assignee: President and Fellows of Harvard College
    Inventor: Debajit K. Biswas